Skip to main content

Table 3 Medication class in relation to number of falls

From: Falls and long-term care: a report from the care by design observational cohort study

Medication N of residents taking each med.
N = 395
0 (N = 171) 1 (N = 106) 2-4 (N = 79) 5+ (N = 34) P-value
Typical antipsychotics 30 9 (30%) 9 (30%) 8 (27%) 4 (13.3%) 0.4
Atypical antipsychotics 156 66 (42.3%) 41 (26.3%) 33 (21.2%) 14 (9.0%) 0.96
SSRI/SNRI 219 97 (44.3%) 47 (21.5%) 51 (23.3%) 22 (10.0%) 0.03
Diuretic 193 85 (44.0%) 52 (26.9%) 36 (18.7%) 16 (8.3%) 0.94
Beta blocker 186 82 (44.1%) 48 (25.8%) 36 (19.4%) 17 (9.1%) 0.95
CCB 104 41 (39.4%) 29 (27.9%) 23 (22.2%) 8 (7.7%) 0.81
ARB 54 27 (50%) 11 (20.3%) 12 (20.45) 2 (3.7%) 0.31
Opioid 211 92 (43.65) 61 (28.9%) 41 (19.4%) 17 (8.1%) 0.83
Statin 149 68 (45.6%) 39 (26.2%) 30 (20.1%) 10 (6.7%) 0.72
Diabetic 106 45 (42.5%) 33 (31.1%) 20 (18.95) 7 (6.6%) 0.62
Bisphosphonate 64 28 (43.8%) 13 (20.3%) 17 (26.6%) 6 (9.4%) 0.41
Benzodiazepines 164 74 (45.1%) 53 (32.3%) 26 (15.9%) 10 (6.1%) 0.05
  1. CCB Calcium Chanel Blocker, ARB Angiotensin Receptor Blocker, SSRI/SNRI Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinepherine Reuptake Inhibitors